Age and Gender Differences in Urea and Creatinine Levels among Diabetic Patients: A Retrospective Observational Study From a Tertiary Hospital in Yogyakarta, Indonesia

Authors

  • Yoni Astuti Biochemistry Department, School of Meddicine, Faculty of Medicine and Health Sciences.Universitas Muhammadiyah Yogyakarta, Jl Brawijaya, Tamantirto, KAsihan Bantul, DI Yogyakarta , Indonesia

DOI:

https://doi.org/10.51601/ijhp.v6i1.623

Keywords:

Diabetes Mellitus; Serum Urea; Serum Creatinine; Renal Function; Age and Gender Differences.

Abstract

Diabetes mellitus is a major global health problem associated with progressive renal complications, including diabetic nephropathy. Serum urea and creatinine are widely used biomarkers to assess renal function, yet their interpretation may be influenced by age and gender differences.This study aimed to analyze differences in urea and creatinine levels among diabetic patients based on age and gender and to evaluate their statistical significance.A retrospective observational study was conducted using medical record data from PKU Muhammadiyah Hospital, Yogyakarta, Indonesia, from Januari to December2025. Patients with complete data on age, gender, urea, and creatinine were included, while incomplete records were excluded. Subjects were stratified into three age groups: ≤50, 51–60, and ≥61 years. Independent sample t-tests were used to compare biomarker levels between males and females within each age group (p < 0.05 considered significant).Mean urea levels increased progressively with age in both genders. Male patients showed a consistent increase in both urea and creatinine levels across age groups, whereas females demonstrated less consistent creatinine trends. Significant gender differences were observed in the ≤50 years group for urea (p = 0.004) and creatinine (p = 0.042), while no significant differences were found in older groups. High variability in biomarker levels was observed, particularly among elderly patients.Age significantly influences urea levels in diabetic patients, while gender differences are more pronounced in younger individuals. These findings highlight the importance of age- and gender-specific interpretation of renal biomarkers in diabetes management.

Downloads

Download data is not yet available.

References

[1] Afkarian, M., Zelnick, LR ., Hall, YN., et al (2016). Clinical manifestations of kidney disease among US adults with diabetes. *JAMA*, 316(6), 602–610.

[2] Inker, L. A., Schmid CH., Tighiouart, H., et al. (2012). Estimating GFR using creatinine and cystatin C. *New England Journal of Medicine*, 367(1), 20–29.

[3] Levey, AS., Inker, L. A., Schmid CH., et al. (2009). A new equation to estimate GFR. *Annals of Internal Medicine*, 150(9), 604–612.

[4] Neugarten, J., And Silbiger., (2018). Gender and renal disease progression. *Kidney International*, 93(2), 276–283.

[5] Thomas, M. C., Brownlee, M., Susztak, K ., et al.(2015). Diabetic kidney disease. *Nature Reviews Disease Primers*, 1, 15018.

[6] Tuttle, KR., Bakris GL; Bilous, RW (2014). Diabetic kidney disease. *Diabetes Care*, 37(10), 2864–2883.

[7] Heerspink, H. J. L., Bakris GL; Bilous, RWet al. (2020). Kidney outcomes in diabetes. *New England Journal of Medicine*, 383, 1436–1446.

[8] Levin, A and Steven PE. (2013). KDIGO clinical guideline. *Kidney International Supplements*, 3(1), 1–150.

[9] Cohen, J. (1992). Statistical power analysis. *Psychological Bulletin*, 112(1), 155–159.

[10] Altman, D. G., & Bland, J. M. (1995). Statistical considerations. *BMJ*, 311, 485.

[11] Hanouneh M, Tcheugui JBE, Bernard G Jaar BG, et al . 2021. Recent advances in diabetic kidney disease. BMC Med.17;19(1):180. doi: 10.1186/s12916-021-02050-0.

[12] Wang N, Zhang C.2025. Pathogenesis of DKD. Front. Med., 08 August 2025 .Sec. Nephrology.

[13] Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1631053

[14] Khandker SS., Kundu, S., Ahmed, F, 2026. Biomarkers in diabetic nephropathy. Curr Issues Mol Biol. 2026 Feb 2;48(2):167. doi: 10.3390/cimb48020167

[15] Neugarten J and Golestaneh L. 2013. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. . 2013 Sep;20(5):390-5. doi: 10.1053/j.ackd.2013.05.004.

[16] Lin X, Li, l., Zang, K., et al 2025. A systematic review and meta-analysis of microRNAs in the diagnosis of early diabetic kidney disease. Front. Endocrinol., Sec. Renal Endocrinology.Volume 16 - 2025 https://doi.org/10.3389/fendo.2025.1432652

[17] Cusumano AM., Martins CT ., Rosa-Diez GJ 2021. The Glomerular Filtration Rate: From the Diagnosis of Kidney Function to a Public Health Tool. Front. Med., 25 November 2021.Sec. Nephrology .Volume 8 - 2021 | https://doi.org/10.3389/fmed.2021.769335

[18] Lin S., Shu Z., Zhou M., et.al. 2026. Inflammatory mechanisms in diabetic nephropathy: emerging insights and targeted therapeutics. Front. Med., 16 January 2026. Sec. Nephrology.Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1722159

[19] Concepción M, Quiroz J, Suarez J., et.al. 2025. Novel Biomarkers for the diagnosis of diabetic nephropathy. Caspian J Intern Med. 2024 Aug 1;15(3):382–391. doi: 10.22088/cjim.15.3.382

[20] Tsai YC, Wu PY, Lai TS., et.al. 2025. Taiwan consensus recommendations for primary care of chronic kidney disease. Journal of the Formosan Medical Association, ttps://doi.org/10.1016/j.jfma.2025.11.016

[21] Altman DG, Bland JM. Statistical reliability.2025. Ito H., Yamaguchi H., Inoue M. 2025. Reliability and Validity of the Articulation Motion Assessment System Using a Rotary Encoder. Biomechanics 2025, 5(1), 2; https://doi.org/10.3390/biomechanics5010002

[22] Luk AOY., Fan Y, Fan B, et al.2025. Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants. Diabetelogia. Volume 68, pages 2386–2404, (2025)

[23] KDIGO implementation study. *Front Nephrol*. 2025. ([Frontiers][8]). Iaina , El’Nasasra ,HH.,Anat Reiner-Benaim AR., et al . 2025. Real-world implementation of the 2020 KDIGO guidelines for diabetes management in chronic kidney disease: a single-center retrospective study. Front. Nephrol., 15 .Sec. Clinical Research in Nephrology. Volume 5 - 2025 | https://doi.org/10.3389/fneph.2025.1664369

[24] Mayne KJ., Sullivan MK & Lees JS., 2023. Sex and gender differences in the management of chronic kidney disease and hypertension. Journal of Human Hypertension volume 37, pages649–653 (2023)

[25] Yamamoto S., Arai Y .,Kosaka T. et. al. 2025. Healthy aging and aging-related kidney diseases: lessons from centenarians.. Clinical Kidney Journal. 2025 Sep 12;18(Suppl 2):ii1–ii9. doi: 10.1093/ckj/sfaf284

[26] Cinezan C and Rus CB. 2026. An Integrated Clinical and Biomarker Model Using Penalized Regression to Predict In-Hospital Mortality in Acute Pulmonary Embolism J Clin Med. 2026 Feb 6;15(3):1308. doi: 10.3390/jcm15031308

[27] Sherry AD.,, Msaouel P., Miller AM . et.al. 2025. Reproducibility of Statistically Significant Phase III Oncology Trials: An In Silico Meta-Epidemiological Analysis. Eur J Cancer. 2025 Jul 4;226:115596. doi: 10.1016/j.ejca.2025.115596

[28] Abdelhag ME. 2026.. A Systematic Review of Machine Learning Methods for Chronic Kidney Disease Diagnosis and Prediction (2020-2025). February 2026.The Saudi Journal of Applied Sciences and Technology 2(1) . DOI:10.63908/prv7rm86.

Downloads

Published

2026-04-24

How to Cite

Astuti, Y. (2026). Age and Gender Differences in Urea and Creatinine Levels among Diabetic Patients: A Retrospective Observational Study From a Tertiary Hospital in Yogyakarta, Indonesia. International Journal of Health and Pharmaceutical (IJHP), 6(1), 545–552. https://doi.org/10.51601/ijhp.v6i1.623

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.